Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

B.1.526 SARS-CoV-2 variants identified in New York City are neutralized by vaccine-elicited and therapeutic monoclonal antibodies

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.03.24.436620Source: DataRank Database

B.1.526 SARS-CoV-2 variants identified in New York City are neutralized by vaccine-elicited and therapeutic monoclonal antibodies is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2021). On theSindex it has a DataRank of 0. It has been cited 39 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access39 citations

Download PDF

Cite:

Linked data & code

pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)OA: greenTopics (36)IDs (PubMed, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Belinda M. Dcosta ORCID,Marie I. Samanovic ORCID,Mark J. Mulligan ORCID,Nathaniel R. Landau ORCID,Takuya Tada ORCID

Live enrichment

PubMed:33791698 OpenAlex:https://openalex.org/W3138429991

National Institutes of Health

Grant: 1DP1DA046100-01

Therapeutic Dendritic Cell Vaccine for HIV

National Institutes of Health

Grant: 5K08AI120898-03

Lentiviral Vector Vaccine for HIV-1

National Institutes of Health

Grant: 5R33AI122390-04

Dendritic Cell Vaccine for Controlling the Latent Reservoir

National Institutes of Health

Grant: 5UM1AI148574-06

Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU)

NIDA NIH HHS

Grant: DP1 DA046100

NIAID NIH HHS

Grant: R01 AI058864

greenLicense: CC BY

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2021/03/24/2021.03.24.436620.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2021.03.24.436620

repositoryhttps://doi.org/10.1101/2021.03.24.436620

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33791698

Fields of Study

SARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testingCOVID-19 Clinical Research Studies0303 health sciences03 medical and health sciences

Keywords

VirologyMonoclonal antibodySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakAntibodyMedicineImmunologyInfectious disease (medical specialty)OutbreakInternal medicinePfizer BNT162b2COVID-19 VaccinesSARS-CoV-2VaccinationAntibodies, MonoclonalCOVID-19Observationneutralizationspike proteinAntibodies, ViralModerna mRNA-1273MicrobiologyAntibodies, NeutralizingQR1-502Cell LineHEK293 CellsB.1.526Spike Glycoprotein, CoronavirusHumansNew York City

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being